Cosmo Pharmaceuticals N.V., a global leader in AI-powered healthcare and specialty pharmaceuticals, has renewed its multi-year manufacturing and supply agreement with Takeda for Mesalazine
Eli Lilly's weight loss drug Mounjaro has rocketed through the Indian pharma market, quickly surging to ?100 crore in the first four months of launch, according to PharmaTrac data. Mounjaro sales were already just shy of ?50 crore for July alone...
India's pharmaceutical and medical device supply chain is on the brink of crisis as confusion surrounding the Ministry of Steel's recent mandate raises questions about the availability of critical components including surgical blades, needles, and...
As demand grows for microbiome-safe and skin-type-specific hygiene products, how are Indian brands rethinking personalization across formulation, packaging, and user engagement strategies
.jpeg)
The CDMO pharmaceutical industry has shifted from being a quiet back-office partner to becoming one of the most strategic enablers in modern drug development. In today’s competitive pharma landscape, where timelines are compressed, regulatory comple
According to Orchid Pharma, the Court of France has issued an order in favor of the company, allowing it to purchase Allecra Therapeutics SAS's assets as of August 1, 2025.
The Association of Gynecological Robotic Surgeons of India (AGRS)'s premier annual event, RoboGynIndia 2025, wrapped off its fourth year in Mumbai with significant engagement and great momentum. "Robotic Surgery in Gynecology—Redefining Boundaries"
India’s Contract Development and Manufacturing Organizations (CDMOs) are quickly emerging as global leaders in personalised nutraceuticals by integrating precision, creativity, and efficiency to meet the skyrocketing global demand for functional...
Eli Lilly and Company (India) has declared the official launching of its new technology and innovation location in Hyderabad; a new strategic centre for enhanced digital and technology capabilities that will drive efficiencies through Lilly’s global
India’s bulk drug imports maintained their downward trend in FY26 for the third consecutive month. June 2025 showed a 12.36% decrease in bulk drug imports at $327.05 million compared to $373.18 million in previous year...
, CDSCO.jpg)
